Patients choose: risky cure or safer control in bone marrow cancer trial
NCT ID NCT04217356
Summary
This study aims to find out which treatment works better for people with high-risk myelofibrosis, a serious bone marrow cancer. Participants choose between a stem cell transplant (which could cure the disease but has serious risks) or the best available non-transplant drug therapy (which controls symptoms but isn't a cure). Researchers will then follow 90 patients to compare survival rates and quality of life between the two groups.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOFIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cross Cancer Institute
Edmonton, Alberta, T6G2G3, Canada
-
Nova Scotia Health Authority
Halifax, Nova Scotia, B3H2Y9, Canada
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G2M9, Canada
-
St. Paul's Hospital
Vancouver, British Columbia, V6E1M7, Canada
-
Tom Baker Cancer Centre
Calgary, Alberta, T2N4N2, Canada
Conditions
Explore the condition pages connected to this study.